All lobbying filings
ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC)
Lobbying for BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO) · Trade association
Filing
1st Quarter - Report
Lobbying activity
3
Issues related to reimbursement under Medicare Part B and Part D; Most Favored Nation (MFN).
Issues related to drug pricing, generally; 340B Drug Pricing Program; pharmacy benefit managers; drug patents and patent reporting requirements; H.R. 1262/S. 932, Give Kids a Chance Act.
BIOSECURE Act/S. Amdt. 3236 to S. 2296, the National Defense Authorization Act for FY2026.